VETINUITY
FDA lists human-labeled dexmedetomidine injection in shortage, while Dexdomitor provides 0.1 mg/mL and 0.5 mg/mL veterinary formulations.
FDA lists human-labeled dexmedetomidine hydrochloride injection in shortage with variable availability across NDCs, while veterinary Dexdomitor is approved under NADA 141-267.
Dexmedetomidine: human-labeled FDA records matched to our veterinary drug catalog.
| FDA field | Product-specific value |
|---|---|
| Record 1 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-1596-10 |
| Record 2 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1) |
| Company | Amneal Pharmaceuticals |
| First posted | 04/10/2020 |
| FDA updated | 10/05/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 70121-1388-1 |
| Record 3 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24) |
| Company | HQ Specialty Pharma |
| First posted | 04/10/2020 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Marketed by WG Critical Care |
| Package NDC | 44567-602-24 |
| Record 4 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93) |
| Company | Accord Healthcare Inc. |
| First posted | 04/10/2020 |
| FDA updated | 09/15/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Discontinuation of the manufacture of the drug |
| Package NDC | 16729-432-93 |
| Record 5 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95) |
| Company | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| First posted | 04/10/2020 |
| FDA updated | 10/05/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Marketed by Sandoz Inc.; Customer service: 800-525-8747 |
| Package NDC | 0781-3494-95 |
| Record 6 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24) |
| Company | HQ Specialty Pharma |
| First posted | 04/10/2020 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Marketed by WG Critical Care |
| Package NDC | 44567-603-24 |
| Record 7 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95) |
| Company | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| First posted | 04/10/2020 |
| FDA updated | 10/05/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Marketed by Sandoz Inc.; Customer service: 800-525-8747 |
| Package NDC | 0781-3493-95 |
| Record 8 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1) |
| Company | Amneal Pharmaceuticals |
| First posted | 04/10/2020 |
| FDA updated | 10/05/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 70121-1389-1 |
| Record 9 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) |
| Company | Accord Healthcare Inc. |
| First posted | 04/10/2020 |
| FDA updated | 09/15/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Discontinuation of the manufacture of the drug |
| Package NDC | 16729-239-93 |
| Record 10 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-0155-02 |
| Record 11 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25) |
| Company | Hikma Pharmaceuticals USA, Inc. |
| First posted | 04/10/2020 |
| FDA updated | 10/14/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Additional product will be made available as it is released. |
| Package NDC | 0143-9532-25 |
| Record 12 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-2815-01 |
| Record 13 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02) |
| Company | Mylan Institutional, a Viatris Company |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 67457-251-02 |
| Record 14 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58) |
| Company | Gland Pharma Limited |
| First posted | 04/10/2020 |
| FDA updated | 10/21/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Distributed by DRL |
| Package NDC | 43598-975-58 |
| Record 15 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 63323-671-50 |
| Record 16 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04) |
| Company | HQ Specialty Pharma |
| First posted | 04/10/2020 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Marketed by WG Critical Care |
| Package NDC | 44567-601-04 |
| Record 17 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10) |
| Company | Par Health, USA LLC |
| First posted | 04/10/2020 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD; Please check wholesalers for inventory |
| Package NDC | 42023-187-10 |
| Record 18 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02) |
| Company | Eugia US LLC |
| First posted | 04/10/2020 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-209-02 |
| Record 19 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7) |
| Company | Amneal Pharmaceuticals |
| First posted | 04/10/2020 |
| FDA updated | 10/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 70121-1389-7 |
| Record 20 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24) |
| Company | Baxter Healthcare |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 43066-555-24 |
| Record 21 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25) |
| Company | Par Health, USA LLC |
| First posted | 04/10/2020 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Please check wholesalers for inventory |
| Package NDC | 42023-146-25 |
| Record 22 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58) |
| Company | Gland Pharma Limited |
| First posted | 04/10/2020 |
| FDA updated | 10/21/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Distributed by DRL |
| Package NDC | 43598-976-58 |
| Record 23 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24) |
| Company | Baxter Healthcare |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-9555-24 |
| Record 24 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10) |
| Company | Azurity Pharmaceuticals, Inc |
| First posted | 04/10/2020 |
| FDA updated | 10/15/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Distributed by Civica |
| Package NDC | 72572-127-10 |
| Record 25 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03) |
| Company | Meitheal Pharmaceuticals, Inc. |
| First posted | 04/10/2021 |
| FDA updated | 08/27/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 71288-505-03 |
| Record 26 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10) |
| Company | Mylan Institutional, a Viatris Company |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 67457-925-10 |
| Record 27 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-1454-20 |
| Record 28 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42) |
| Company | Gland Pharma Limited |
| First posted | 04/10/2020 |
| FDA updated | 10/21/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Marketed by Piramal Critical Care Inc.: 800-414-1901 |
| Package NDC | 66794-230-42 |
| Record 29 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-1174-10 |
| Record 30 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-7853-24 |
| Record 31 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50) |
| Company | Mylan Institutional, a Viatris Company |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 67457-924-50 |
| Record 32 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-7838-24 |
| Record 33 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12) |
| Company | Baxter Healthcare |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 43066-557-12 |
| Record 34 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-7875-12 |
| Record 35 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8) |
| Company | Amneal Pharmaceuticals |
| First posted | 04/10/2020 |
| FDA updated | 10/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 70121-1388-8 |
| Record 36 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04) |
| Company | HQ Specialty Pharma |
| First posted | 04/10/2020 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Marketed by WG Critical Care |
| Package NDC | 44567-600-04 |
| Record 37 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04) |
| Company | Somerset Therapeutics, LLC |
| First posted | 04/10/2020 |
| FDA updated | 10/27/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 70069-758-04 |
| Record 38 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12) |
| Company | Baxter Healthcare |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0338-9557-12 |
| Record 39 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08) |
| Company | Azurity Pharmaceuticals, Inc |
| First posted | 04/10/2020 |
| FDA updated | 10/15/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Distributed by Wilshire Pharmaceuticals, Inc. |
| Package NDC | 52536-126-08 |
| Record 40 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-3301-10 |
| Record 41 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-4596-20 |
| Record 42 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-1434-01 |
| Record 43 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD |
| Package NDC | 63323-421-02 |
| Record 44 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10) |
| Company | Azurity Pharmaceuticals, Inc |
| First posted | 04/10/2020 |
| FDA updated | 10/15/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Distributed by Wilshire Pharmaceuticals, Inc. |
| Package NDC | 52536-125-10 |
| Record 45 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20) |
| Company | Par Health, USA LLC |
| First posted | 04/10/2020 |
| FDA updated | 11/02/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Estimated recovery: TBD; Please check wholesalers for inventory |
| Package NDC | 42023-186-20 |
| Record 46 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04) |
| Company | Somerset Therapeutics, LLC |
| First posted | 04/10/2020 |
| FDA updated | 10/27/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 70069-759-04 |
| Record 47 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Expected recovery: TBD |
| Package NDC | 63323-671-00 |
| Record 48 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-1660-50 |
| Record 49 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95) |
| Company | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
| First posted | 04/10/2020 |
| FDA updated | 10/05/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Marketed by Sandoz Inc.; Customer service: 800-525-8747 |
| Package NDC | 0781-3495-95 |
| Record 50 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-1638-02 |
| Record 51 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20) |
| Company | Fresenius Kabi USA, LLC |
| First posted | 04/10/2020 |
| FDA updated | 11/03/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Expected recovery: TBD |
| Package NDC | 63323-671-20 |
| Record 52 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10) |
| Company | Eugia US LLC |
| First posted | 04/10/2020 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-296-10 |
| Record 53 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08) |
| Company | Azurity Pharmaceuticals, Inc |
| First posted | 04/10/2020 |
| FDA updated | 10/15/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Distributed by Civica |
| Package NDC | 72572-128-08 |
| Record 54 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) |
| Company | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) |
| First posted | 04/10/2020 |
| FDA updated | 10/14/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Unavailable |
| FDA additional information | Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229 |
| Package NDC | 83634-600-02 |
| Record 55 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20) |
| Company | Pfizer Inc. |
| First posted | 04/10/2020 |
| FDA updated | 11/06/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Not stated |
| Package NDC | 0409-1660-20 |
| Record 56 | Dexmedetomidine Hydrochloride Injection |
| FDA generic name | Dexmedetomidine Hydrochloride Injection |
| FDA shortage status | Current |
| Dosage form | Injection |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10) |
| Company | Eugia US LLC |
| First posted | 04/10/2020 |
| FDA updated | 10/19/2026 |
| Resolved date | Not stated |
| Discontinued date | Not stated |
| Human therapeutic category | Anesthesia |
| Presentation availability | Available |
| FDA additional information | Check wholesalers for inventory |
| Package NDC | 55150-297-10 |
FDA lists human-labeled dexmedetomidine in shortage as of 2026-11-07.
Dexmedetomidine is approved for veterinary use under NADA 141-267 as Dexdomitor (Zoetis Inc.) in 0.1 mg/mL (15 mL multidose vial) and 0.5 mg/mL (10 mL multidose vial) sterile injectable solutions for dogs and cats. Information regarding animal drug shortages is maintained separately by the FDA Center for Veterinary Medicine.
Vetinuity supports treatment options with citations and dose math.
FDA shortage status details for clindamycin injection, including manufacturer availability and supply dates.
Track veterinary and human drug shortages using FDA Center for Veterinary Medicine tables and CDER records.
FDA lists human-labeled dextrose injection in shortage, with various concentrations showing available, limited, or unavailable supply.
FDA shortage status by lidocaine injection presentation, plus lidocaine and bupivacaine onset and duration for local blocks in dogs and cats.
Yes, FDA lists human-labeled dexmedetomidine hydrochloride injection in shortage. Stock status varies by NDC and manufacturer, with specific presentations remaining Available while others are Unavailable or discontinued.
In the saved FDA dexmedetomidine records, Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10) from Pfizer Inc. has availability listed as Available. This describes that presentation in the checked snapshot.
As of 2026-11-07, dexmedetomidine is absent from the FDA CVM animal drug shortage table. This does not establish product availability.
Vetinuity explains clinical options with journal citations.
The veterinarian diagnoses and prescribes.